CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.

This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions. 

TAVR has already transformed care for patients with severe aortic stenosis. Will it make a similar impact on the treatment of aortic regurgitation?

Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

The tech giant is making each model publicly available so that researchers and developers can have access to the updated technology. 

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.

This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement.